HomeAI · summaries
Storia in 10 fonti
Small Biotech Catapults To Record High On $10.6 Billion Deal
GSK made an all-cash bid to buy the small cancer-focused biotech company for $10.6 billion.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
- ·
cityam.com
GSK snaps up US cancer treatment firm Nuvalent in $10.6bn deal
GSK has bought a Boston-based biopharmaceutical firm that specialises in lung cancer treatment in a $10.6bn deal.
